Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(36 sites)
United States
Research Site, Birmingham, Alabama Research Site, Phoenix, Arizona Research Site, La Jolla, California Research Site, Los Angeles, California Research Site, San Francisco, California Research Site, Aurora, Colorado Research Site, Denver, Colorado Research Site, Jacksonville, Florida Research Site, Miami, Florida Research Site, Tampa, Florida Research Site, Atlanta, Georgia Research Site, Chicago, Illinois Research Site, Iowa City, Iowa Research Site, Boston, Massachusetts Research Site, Boston, Massachusetts Research Site, Ann Arbor, Michigan Research Site, Detroit, Michigan Research Site, Minneapolis, Minnesota Research Site, Rochester, Minnesota Research Site, Omaha, Nebraska Research Site, Hackensack, New Jersey Research Site, Buffalo, New York Research Site, New York, New York Research Site, Stony Brook, New York Research Site, Charlotte, North Carolina Research Site, Durham, North Carolina Research Site, Nashville, Tennessee Research Site, Nashville, Tennessee Research Site, Austin, Texas Research Site, Dallas, Texas Research Site, Houston, Texas Research Site, Salt Lake City, Utah Research Site, Charlottesville, Virginia Research Site, Edmonds, Washington Research Site, Seattle, Washington Research Site, Milwaukee, Wisconsin